BK-NM-AMT
| Clinical data | |
|---|---|
| Other names | βk-NM-αMT; β-Keto-N-methyl-αMT; β-Keto-N-methyl-AMT; α,N-dimethyl-β-ketotryptamine; 3-Indoylmethcathinone; β-Oxo-α-methyl-NMT |
| Drug class | Serotonin–dopamine releasing agent; Entactogen |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| Chemical and physical data | |
| Formula | C12H14N2O |
| Molar mass | 202.257 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
BK-NM-AMT, or βk-NM-αMT, also known as β-keto-N-methyl-αMT or α,N-dimethyl-β-ketotryptamine, as well as 3-indoylmethcathinone, is a serotonin–dopamine releasing agent (SDRA) and putative entactogen of the tryptamine, α-alkyltryptamine, and β-ketotryptamine families.